Literature DB >> 28102707

Patient dosimetry audit for establishing local diagnostic reference levels for nuclear medicine CT.

Matthew Gardner1, Ngonidzashe M Katsidzira1, Erin Ross2, Elizabeth A Larkin1.   

Abstract

OBJECTIVE: To establish a system for patient dosimetry audit and setting of local diagnostic reference levels (LDRLs) for nuclear medicine (NM) CT.
METHODS: Computed radiological information system (CRIS) data were matched with NM paper records, which provided the body region and dose mode for NMCT carried out at a large UK hospital. It was necessary to divide data in terms of the NM examination type, body region and dose mode. The mean and standard deviation dose-length products (DLPs) for common NMCT examinations were then calculated and compared with the proposed National Diagnostic Reference Levels (NDRLs). Only procedures which have 10 or more patients will be used to suggest LDRLs.
RESULTS: For most examinations, the mean DLPs do not exceed the proposed NDRLs. The bone single-photon emission CT/CT lumbar spine data clearly show the need to divide data according to the purpose of the scan (dose mode), with mean (±standard error) DLPs ranging from 51 ± 5 mGy cm (low dose) to 1086 ± 124 mGy cm (metal dose).
CONCLUSION: A system for NMCT patient dose audit has been developed, but there are non-trivial challenges which make the process labour intensive. These include limited information provided by CRIS downloads, dependence on paper records and limited number of examinations available owing to the need to subdivide data. Advances in knowledge: This article demonstrates that a system can be developed for NMCT patient dose audit, but also highlights the challenges associated with such audit, which may not be encountered with more routine audit of radiology CT.

Entities:  

Mesh:

Year:  2017        PMID: 28102707      PMCID: PMC5601536          DOI: 10.1259/bjr.20160850

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee.

Authors: 
Journal:  Nucl Med Commun       Date:  2000-01       Impact factor: 1.690

2.  Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT.

Authors:  Ngoneh Jallow; Paul Christian; John Sunderland; Michael Graham; John M Hoffman; Jonathon A Nye
Journal:  J Nucl Med       Date:  2015-11-12       Impact factor: 10.057

3.  Multi-slice computed tomography (MSCT): the dose challenge of the new revolution.

Authors:  Stephen J Golding
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

4.  Establishment of a comprehensive set of regional DRLs for CT by means of electronic X-ray examination records.

Authors:  P Charnock; A F Dunn; B M Moores; J Murphy; R Wilde
Journal:  Radiat Prot Dosimetry       Date:  2014-07-22       Impact factor: 0.972

5.  Establishing local and regional DRLs by means of electronic radiographical X-ray examination records.

Authors:  P Charnock; B M Moores; R Wilde
Journal:  Radiat Prot Dosimetry       Date:  2013-05-07       Impact factor: 0.972

6.  National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.

Authors:  Cécile Etard; David Celier; Patrice Roch; Bernard Aubert
Journal:  Radiat Prot Dosimetry       Date:  2012-05-14       Impact factor: 0.972

7.  The EANM practice guidelines for bone scintigraphy.

Authors:  T Van den Wyngaert; K Strobel; W U Kampen; T Kuwert; W van der Bruggen; H K Mohan; G Gnanasegaran; R Delgado-Bolton; W A Weber; M Beheshti; W Langsteger; F Giammarile; F M Mottaghy; F Paycha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.